Evidence map›Paper›PMID 37873144›Full record

ArticlebioRxiv : the preprint server for biology2023

Compact Programmable Control of Protein Secretion in Mammalian Cells.

Alexander E Vlahos, Connor C Call, Samarth E Kadaba, Siqi Guo, Xiaojing J Gao

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 5 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Alexander E VlahosDepartment of Chemical Engineering, Stanford University, Stanford, CA, 94305, USA.
Connor C CallDepartment of Chemical Engineering, Stanford University, Stanford, CA, 94305, USA.
Samarth E KadabaDepartment of Chemical Engineering, Stanford University, Stanford, CA, 94305, USA.
Siqi GuoDepartment of Chemical Engineering, Stanford University, Stanford, CA, 94305, USA.
Xiaojing J GaoDepartment of Chemical Engineering, Stanford University, Stanford, CA, 94305, USA.
Stanford University · US

Funding

Supplement to Enhance Wellness and Resiliency in the Graduate EnvironmentT32GM007276 · NIGMS · STANFORD UNIVERSITY · PI MORRISON, ASHBY J. · 1985 to 2023
$32.9M
Synthetic DNA-free Circuits for “Scarless” Programming of Mammalian CellsR00EB027723 · NIBIB · STANFORD UNIVERSITY · PI GAO, XIAOJING J · 2020 to 2022
$747k
NIBIB NIH HHS R00 EB027723NIGMS NIH HHS T32 GM007276
6 · The paper itself

Abstract

Synthetic biology currently holds immense potential to engineer the spatiotemporal control of intercellular signals for biomedicine. Programming behaviors using protein-based circuits has advantages over traditional gene circuits such as compact delivery and direct interactions with signaling proteins. Previously, we described a generalizable platform called RELEASE to enable the control of intercellular signaling through the proteolytic removal of ER-retention motifs compatible with pre-existing protease-based circuits. However, these tools lacked the ability to reliably program complex expression profiles and required numerous proteases, limiting delivery options. Here, we harness the recruitment and antagonistic behavior of endogenous 14-3-3 proteins to create RELEASE-NOT to turn off protein secretion in response to protease activity. By combining RELEASE and RELEASE-NOT, we establish a suite of protein-level processing and output modules called Compact RELEASE (compRELEASE). This innovation enables functions such as logic processing and analog signal filtering using a single input protease. Furthermore, we demonstrate the compactness of the post-translational design by using polycistronic single transcripts to engineer cells to control protein secretion via lentiviral integration and leverage mRNA delivery to selectively express cell surface proteins only in engineered cells harboring inducible proteases. CompRELEASE enables complex control of protein secretion and enhances the potential of synthetic protein circuits for therapeutic applications, while minimizing the overall genetic payload.

Indexed as

14-3-3 proteinsintercellular communicationmRNA deliveryproteasesprotein circuitssynthetic biology

Identifiers

PMID37873144
PMCPMC10592972
OpenAlexW4387372802

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.